Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2bxa | C1F | Serum albumin |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 2bxa | C1F | Serum albumin | / | 1.000 | |
| 2ydf | IO3 | Serum albumin | / | 0.645 | |
| 1hk2 | T44 | Serum albumin | / | 0.607 | |
| 1hk1 | T44 | Serum albumin | / | 0.578 | |
| 2bx8 | AZQ | Serum albumin | / | 0.575 | |
| 3lu7 | IPX | Serum albumin | / | 0.564 | |
| 2bxi | AZQ | Serum albumin | / | 0.551 | |
| 1hk3 | T44 | Serum albumin | / | 0.538 | |
| 3lu6 | IMX | Serum albumin | / | 0.527 | |
| 2bxo | OPB | Serum albumin | / | 0.525 | |
| 2xvu | 9DN | Serum albumin | / | 0.519 | |
| 4z69 | DIF | Serum albumin | / | 0.468 | |
| 4fj0 | NAP | 17beta-hydroxysteroid dehydrogenase | / | 0.459 | |
| 3tdv | GDP | Gentamicin resistance protein | / | 0.457 | |
| 1obn | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.453 | |
| 4l9z | COA | L-malyl-CoA/beta-methylmalyl-CoA lyase | 4.1.3.24 | 0.453 | |
| 2nli | FMN | Lactate oxidase | / | 0.449 | |
| 4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
| 3tdl | 11D | Serum albumin | / | 0.447 | |
| 3vn9 | ANK | Dual specificity mitogen-activated protein kinase kinase 6 | 2.7.12.2 | 0.447 | |
| 1crb | RTL | Retinol-binding protein 1 | / | 0.446 | |
| 2eix | FAD | NADH-cytochrome b5 reductase | / | 0.445 | |
| 4bn1 | ADP | Aurora kinase A | 2.7.11.1 | 0.445 | |
| 3tdw | GDP | Gentamicin resistance protein | / | 0.444 | |
| 2vwi | ANP | Serine/threonine-protein kinase OSR1 | 2.7.11.1 | 0.443 | |
| 3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.443 | |
| 4l8u | 9AZ | Serum albumin | / | 0.443 | |
| 1guf | NDP | Enoyl-[acyl-carrier-protein] reductase 1, mitochondrial | 1.3.1.10 | 0.442 | |
| 3lfb | Z87 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.442 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 1r9o | FLP | Cytochrome P450 2C9 | / | 0.441 | |
| 1wlv | COA | Phenylacetic acid degradation protein PaaI | / | 0.441 | |
| 2imk | GTX | AGAP009194-PA | / | 0.441 | |
| 3x2v | ATP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 4lb2 | DM5 | Serum albumin | / | 0.441 | |
| 2cah | NDP | Catalase | 1.11.1.6 | 0.440 | |
| 3ix9 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.440 | |
| 4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.440 |